Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators - Summary - MDSpire

Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators

  • By

  • Kinga K. Tomczak

  • Jason P. Swindle

  • Firas M. Dabbous

  • Donald L. Gilbert

  • George B. Karkanias

  • Sarah D. Atkinson

  • Frederick E. Munschauer

  • Faizan Mazhar

  • Charlotte A. Pettersson

  • Stephen P. Wanaski

  • Timothy M. Cunniff

  • David A. Isaacs

  • June 2, 2026

  • 0 min

Share

Objective:

Add significance of comparing treated vs. untreated groups.

Key Findings:
  • Add context on implications of odds ratios.
Interpretation:

Emphasize potential clinical implications.

Limitations:
  • Add a point about generalizability.
Conclusion:

Reiterate importance of addressing adherence challenges.

Original Source(s)

Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators

  • by Kinga K. Tomczak, Jason P. Swindle, Firas M. Dabbous, Donald L. Gilbert, George B. Karkanias, Sarah D. Atkinson, Frederick E. Munschauer, Faizan Mazhar, Charlotte A. Pettersson, Stephen P. Wanaski, Timothy M. Cunniff, David A. Isaacs

  • June 2, 2026

Related Content

Can Lower Music Levels Preserve Workout Intensity?

Despite preserved exertion perceptions, researchers report limited hearing protection use in group fitness classes.

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma